Eohilia (budesonide oral suspension) — Medica

Eosinophilic esophagitis

Initial criteria

Patient is age ≥ 11 years
Diagnosis of eosinophilic esophagitis confirmed by endoscopic biopsy demonstrating ≥ 15 intraepithelial eosinophils per high-power field
Patient meets ONE of the following (i or ii): i) Patient has received at least 8 weeks of therapy with a proton pump inhibitor OR ii) According to the prescriber, the patient has severe disease with esophageal stricture
Patient meets ONE of the following (i or ii): i) Patient has tried dietary modifications to manage eosinophilic esophagitis OR ii) The prescriber has determined that the patient is not an appropriate candidate for dietary modifications
Patient meets ONE of the following (i or ii): i) Patient is currently receiving a course of Eohilia and additional medication is needed to complete a 12-week course of treatment OR ii) Patient meets ONE of the following (a or b): a) Patient has not been treated with Eohilia within the previous 6 months OR b) According to the prescriber, the patient is experiencing recurrent worsening dysphagia after discontinuing Eohilia therapy
Medication is prescribed by or in consultation with an allergist or gastroenterologist

12 weeks